1992 ·Hualan Biological Engineering Co., Ltd. was founded in XinXiang, Henan, China
1995 ·Human Albumin was approved for manufacturing and marketing in China
1996 ·The first company in China implemented the automatic Apheresis human plasma collecting machine, which guarantees the product quality and donor’s safety.
·“Reputation depends on quality and safety”, Mr. Chen Minzhang, Minister of Health (at the time), made the inscription for the company during his inspection.
·The State Ministry of Health issued the No. 48 document, designating Hualan Bio as the pilot enterprise for the “automatic human plasma collection"
·An enterprise credited with a rating of AAA
1997 ·The first company for the plasma products in China adopted the “Automatic Vial Sterilization and Filling Line” to assure the consistence and stability of the products.
·“Human Immunoglobulin” was approved for manufacturing and marketing.
·Be a member of Chinese Association of Foreign Investment Enterprises.
·Implement the computer-based fingerprint identification system and remote network system for the management of plasma donation centers.
·IVIG (PH4) was approved for marketing.
1998 ·Implement the “LOOK BACK” system to ensure the safety and reliability for all human plasma used in the production.
·Be honored with the Henan Provincial “Excel Foreign Investment Enterprise”.
·The first enterprise received GMP-compliant Certificate for the blood products in China.
·Be awarded as the National Torch High-tech Model Enterprise.
1999 ·PCC, Lyophilized was approved for production and marketing.
2000 ·Human Coagulation Factor VIII, Lyophilized was approved for production and marketing.
·Be evaluated as the National Key High-tech Enterprise by the Ministry of Science and Technology in China.
2001 ·More than 2 virus inactivation processes with different mechanisms were used in the manufacturing of human immunoglobulin and coagulation products to guarantee the safety of the products.
2002 ·Hepatitis B Immunoglobulin is approved for manufacturing and marketing.
·Human Fibrin Sealant, Lyophilized was approved with a National New Drug Certificate and production permission.
·Post-Doctoral Workstation approved by the National Ministry of Personnel was founded in Hualan.
·Human Tetanus Immunoglobulin was approved for manufacturing and marketing.
2003 ·Bio-Pharmaceutical Engineer & Technology Research Center of Henan Province approved by the Provincial Department of Science and Technology was founded in Hualan.
·Top 30 State Pharmaceutical Enterprise.
·Pass the on-site inspection by Indian FDA.
2004 ·Pass the GMP inspection and validation for updating the certificate.
·Products were exported to India.
2005 ·The stock rose more than 1000%.
·The subsidiary company: Hualan Biological Bacterin Co., Ltd. was founded.
2006 ·Be selected by Forbes as the “TOP 100 Enterprises with Greatest Potential in China” for 2 years.
2007 ·Be awarded as the “Top 100 IPO Company” in China
·Influenza Vaccine (Split Virion), Inactivated was approved for manufacturing and marketing.
2009 ·Be awarded as the 20 Best Developing Potential IPO Company in China
·Meningococcal Polysaccharide Vaccine Group ACYW135 was approved for manufacturing and marketing.
2010 ·Top the first among the 100 Best Market Value Management IPO Company in China
·Recombinant Hepatitis B Vaccine was approved for manufacturing and marketing.
2011 · Hualan Bio gained the National Level Enterprise Technology Center and Chinese well-known trademark.
2013 · Hualan Genetic Engineering Co., Ltd was established.
2015 · Influenza Vaccine (Split, Virion), Inactivated passed WHO-PQ.
2016 · WHO On-Site evaluation of Meningococcal Polysaccharide Vaccine Group ACYW135.